| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 84,200 | 02 Jan 2026 | Direct | ||
| LENZ Therapeutics, Inc. | Chief Medical Officer | Restricted Stock Unit | 14,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | 02 Jan 2026 | 2 | $0 | 4 | Chief Medical Officer | 06 Jan 2026, 16:21 |
| LENZ | LENZ Therapeutics, Inc. | 09 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 13 Jan 2025, 17:24 |
| LENZ | LENZ Therapeutics, Inc. | 21 Mar 2024 | 3 | $0 | 4 | Chief Medical Officer | 25 Mar 2024, 20:33 |
| LENZ | LENZ Therapeutics, Inc. | 21 Mar 2024 | 0 | $0 | 3 | Chief Medical Officer | 25 Mar 2024, 20:14 |